Vanda Pharmaceuticals Announces Participation at the Citi 16th Annual BioPharma Virtual Conference

Rhea-AI Summary

Vanda Pharmaceuticals Inc. (VNDA) announced its participation in the Citi 16th Annual BioPharma Virtual Conference from September 8 to September 10, 2021. The company's management will conduct investor meetings during the event. Vanda has also updated its corporate presentation, available on its website under the Investors tab. Vanda Pharmaceuticals is dedicated to developing innovative therapies to meet significant medical needs.

Positive

• Participation in a significant industry conference may enhance visibility and attract potential investors.
• Updated corporate presentation could improve investor understanding of Vanda's strategic direction.

Negative

• None.

News Market Reaction – VNDA

+0.89%

+0.89% Session move

In the trading session that priced this news, VNDA gained 0.89%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WASHINGTON, Sept. 7, 2021 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that Vanda's management will participate at the Citi 16^th Annual BioPharma Virtual Conference taking place between September 8 and September 10, 2021. Vanda management will host investor meetings. Vanda has updated its corporate presentation, which may be accessed on Vanda's website, www.vandapharma.com, by clicking on the Investors tab and following the Corporate Presentation link.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on Twitter @vandapharma.

Corporate Contact:

AJ Jones II
Chief Corporate Affairs and Communications Officer
Vanda Pharmaceuticals Inc.
(202) 734-3400
pr@vandapharma.com

Elizabeth Van Every
Head of Corporate Affairs
Vanda Pharmaceuticals Inc.
(202) 734-3400
pr@vandapharma.com

View original content:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-the-citi-16th-annual-biopharma-virtual-conference-301370818.html

SOURCE Vanda Pharmaceuticals Inc.

FAQ

What event is Vanda Pharmaceuticals participating in?

Vanda Pharmaceuticals is participating in the Citi 16th Annual BioPharma Virtual Conference from September 8 to September 10, 2021.

Where can I find Vanda Pharmaceuticals' updated corporate presentation?

The updated corporate presentation can be accessed on Vanda Pharmaceuticals' website under the Investors tab.

What is the focus of Vanda Pharmaceuticals?

Vanda Pharmaceuticals focuses on developing innovative therapies to address high unmet medical needs.